WILMINGTON, DE - Enovis (NYSE: ENOV), a prominent medical technology company with a market capitalization of $2.54 billion, has announced the appointment of Davide Visentin as the new President of ...

In trading on Monday, shares of Enovis Corp (Symbol: ENOV) crossed below their 200 day moving average of $45.97, changing hands as low as $44.70 per share. Enovis Corp shares are currently trading ...

Delaware-based Enovis Corp. (NYSE: ENOV) on Jan. 27 was approved by the Cedar Park City Council and Cedar Park Type A Corp. for up to $650,000 in performance-based incentives – and potentially ...

WILMINGTON, DE — Enovis Corporation (NYSE: ENOV) is set to host an investor conference call and live webcast on Wednesday, ...

Enovis Corporation Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the ...

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm ...